NASDAQ$BTSG
Brightspring Health Services Inc · Q2 2024 earnings
Q2 2024 earnings ·
Briefing
BTSG Q2 2024 — $400K revenue, 0.10 EPS
If any of these risks materialize, or if any of our assumptions underlying forward-looking statements prove incorrect, actual results and developments may differ materially from those made in or sugge. Brightspring Health Services Inc reported Q2 2024 results. Diluted EPS came in at $0.10. Headline numbers extracted from the Form 10-Q press release; narrative is light because this row was processed without an LLM call.
- Revenue: $400K.
- Diluted EPS: $0.10.
- Operating income: $62K.
- Gross profit: $389K.
Headline financials
Revenue & EPS history
Brightspring Health Services Inc · Revenue · Quarterly
$2.73B
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 8 quarterly earnings reports · overlaid with Q2 2024
+4.4%
Avg return
Earnings day
+7.8%
Avg return
5 days after
+15.8%
Avg return
30 days after
75%
6 / 8 earnings
Positive
+16.6%
Q1 2025
Best reaction
-8.7%
Q2 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +9.6% | +9.9% | +28.5% | |
| Q4 2025 | +3.2% | +4.6% | +5.5% | |
| Q3 2025 | +0.5% | -2.3% | +7.8% | |
| Q2 2025 | -4.9% | -0.7% | +14.7% | |
| Q1 2025 | +16.6% | +28.7% | +33.0% | |
| Q3 2024 | +15.2% | +22.6% | +28.9% | |
| Q2 2024 | -8.7% | -8.1% | +2.6% | |
| Q1 2024 | +3.8% | +7.7% | +5.5% |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro